Telehealth & HIV: After COVID-19
Resource updated 03/15/2023
Resource updated 03/15/2023
Implementation of innovations for End the HIV Epidemic (EHE) efforts requires innovative research/community collaborations. This session presents LA County’s efforts to prepare for long-acting injectable treatment, Miami’s pilot of telemedicine for test-and-treat at a syringe services program, and Philadelphia’s partnership to evaluate a U=U campaign.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 05/23/2023
Resource updated 04/07/2023
Resource updated 06/09/2022
Resource updated 04/10/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 01/08/2024
Resource updated 11/29/2023
Resource (Conference Presentation) updated 09/14/2023
This HIV clinic evaluated effectiveness of telemedicine for selected patients during the first year of the COVID-19 pandemic, and found overall viral suppression and retention in care rates were not adversely impacted by switch to telemedicine. They also noted similar rates of telemedicine utilization across demographic criteria.
Resource (Conference Presentation) updated 09/14/2023
Use of patient-reported outcome measures (PROMS) and patient-reported experience measures (PREMS) to help guide quality improvement activities by utilizing the patient voices and input.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023